The global clinical diagnostic equipment market is estimated to create an incremental opportunity of more than US$ 10 Bn by the end of 2032. The sales of clinical diagnostic equipments are expected to accelerate at a CAGR of 6% to 7% during the forecast period 2022-2032. Rising investments by prominent players for the development and introduction of more accurate and precise diagnostic devices integrated with innovative technologies is anticipated to elevate the demand for clinical diagnostic equipment in the global market.
| Report Attribute | Details |
| Clinical Diagnostic Equipment Market Anticipated Value (2032) | US$ 10 Billion |
| Clinical Diagnostic Equipment Market Projected Growth Rate (2022-2032) | 6% to 7% CAGR |
Clinical diagnostic equipments are medical instruments and devices used to identify & detect the presence and cause of diseases. They examine the nature of the illness, designate a course of treatment, and monitor the effectiveness of intervention for preventing the reappearance of exiting symptoms of the disease.
Though the outbreak of the COVID-19 pandemic negatively impact the growth of several markets, it favored the demand for clinical diagnostic equipments. Diagnostic equipments such as assay kits, blood chemistry analyzers, DNA thermal cycles, and others were extensively used for diagnosis of blood and mucus samples for coronavirus detection. This bolstered the sales of clinical diagnostic equipments in during the pandemic.
These diagnostic equipments are finding a wide range of applications across several medical testing domains such as coagulation testing, blood gas testing, tissue diagnostics, molecular diagnostics, and hematology testing among others. This is projected to propel the demand for clinical diagnostic equipment in the market.
In addition to this, rising emphasis on the introduction of advanced nanotechnology, ensuring more reliable and precise results using clinical diagnostic equipment is estimated to further bolster the growth in the market.
Prevalence of chronic disorders such as arthritis, coronary heart diseases, chronic obstructive pulmonary disease (COPD), and cancer among others is growing at an exponential pace across the globe, fueling the demand for diagnostics and therapeutic devices.
According to a study by the World Cancer Research Fund International, nearly 18.1 Million new cases of cancer were reported globally, out of which over 474,519 new cases of leukemia, also known as blood cancer, were registered in 2020.
Hence, governments across several counties are undertaking a number of initiatives for spreading awareness regarding the early diagnosis of cancer to curb the death due to the disease. For instance, the India Government has announced launches National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Strokes (NPCDCS) for spreading awareness regarding early cancer diagnosis.
As clinical diagnostic equipments are extensively used during medical diagnostics such as hematology testing for examining the blood samples for the diagnosis of cancer such as leukemia, a slew of such initiatives is projected to bolster the growth in the global market.
Despite growing need for clinical diagnostic equipment, high initial cost of investment, cost of maintenance, need for skilled personnel to operate expensive medical devices such as clinical microbiology systems and hematology devices are hindering the growth in the market.
Also, presence of stringent regulatory infrastructure for product approvals by governmental and medical organizations such as the European Medicine Agency is expected to restrain the clinical diagnostic equipment market growth.
As per FMI reveals that North America is forecast to emerge as the most lucrative market for clinical diagnostic equipment between 2022 and 2032.
With rising prevalence of ailments such as chronic disorders, infectious diseases, deficiency disorders, and others across North America, a significant rise in demand for medical equipments for diagnosis and treatment is being experienced across the countries such as U.S. and Canada.
Hence, key players in the market are focusing on research and development (R&D) activities for developing and launching more precise diagnostic equipment to cater to the surging demand. For instance, in 2019, Beckman Coulter, an America manufacturer of medical instruments announced expanding their product portfolio by introducing a new immunoassay system, Access PCT Assay, for design for in-vitro diagnostic testing for sepsis detection and management. A multiplicity of such new products launches is projected to augment the sales in the North America market.
Future Market Insights states that Asia Pacific excluding Japan is anticipated to exhibit rapid growth in the global clinical diagnostic equipment market during the forecast period 2022-2032.
Growing rates of obesity and overweight due to the reduction in physical activity, increasing consumption of sweet food products, and changing lifestyle have resulted in a substantial rise in burden of diabetes across Asia Pacific.
For instance, according to the International Diabetes Federation, nearly 116 million people, or around 10.9% of the adult population across China are reported to be incurring from diabetes in 2019. As clinical diagnostic equipments are used for identifying the presence of diabetes, designating the therapeutic, and monitoring the effect of intervention, growing prevalence of diabetes is estimated to accelerate the demand in the Asia Pacific excluding Japan market.
Some of the leading players in the clinical diagnostic equipment market are Abbott Laboratories, Inc., Siemens Healthineers, Laboratory Corporation of America, LLC, Sonic Healthcare Ltd., Philips Healtcare, Eurofins Scientific, Quest Diagnostics, Inc, GE Healthcare, Fujiflim Holdings, NeoGenomics Laboratories Inc., Fresenius Medical Care, Genoptix, Inc., and others.
Prominent players in the global clinical diagnostic equipment market are aiming at introducing novel products and entering into collaboration, partnership, and acquisition to gain edge in the highly competitive market.
| Report Attribute | Details |
| Growth Rate | CAGR of 6% to 7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By Application:
By Test Type:
By Region:
FMI projects the sales of clinical diagnostic equipment in the market is expected to rise at 6% to 7% value CAGR by 2032
The global clinical diagnostic equipment market is expected to be dominated by North America over the forecast period 2022-2032.
Abbott Laboratories, Inc., Siemens Healthineers, Laboratory Corporation of America, LLC, Sonic Healthcare Ltd., Philips Healtcare, Eurofins Scientific, Quest Diagnostics, Inc, GE Healthcare, Fujiflim Holdings, NeoGenomics Laboratories Inc., Fresenius Medical Care, Genoptix, Inc. are some of the leading players in the prominent clinical diagnostic equipment market.
Explore Similar Insights
Clinical Diagnostic Equipment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
